Overview
Robert Gelfand is an Endocrinologist practicing medicine in New Haven, Connecticut.
His clinical expertise encompasses Diabetic Hyperglycemic Hyperosmolar Syndrome, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Nephrogenic Diabetes Insipidus.
He is actively involved in clinical research, co-authoring 12 peer reviewed articles. Dr. Gelfand is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
Locations
55 Lock St, New Haven, CT 06511
365 Montauk Ave, New London, CT 06320
Additional Areas of Focus
Dr. Gelfand has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Yale University School Of Medicine
Karl Insogna is an Endocrinologist practicing medicine in New Haven, Connecticut. Dr. Insogna is highly rated in 12 conditions, according to our data. His clinical expertise encompasses X-Linked Hypophosphatemia, Hypophosphatemia, Rickets, Parathyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Insogna is currently accepting new patients.
Smilow Cancer Hospital
Silvio Inzucchi is an Endocrinologist practicing medicine in New Haven, Connecticut. Dr. Inzucchi is highly rated in 60 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Low Blood Sugar, and Pituitary Tumor. Dr. Inzucchi is currently accepting new patients.
Yale New Haven Hospital
Clemens Bergwitz is an Endocrinologist practicing medicine in New Haven, Connecticut. Dr. Bergwitz is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Hypophosphatemia, Nephrocalcinosis, Rickets, and Osteoporosis. Dr. Bergwitz is currently accepting new patients.
Frequently Asked Questions about Dr. Robert A. Gelfand
How do I make an appointment with Dr. Robert A. Gelfand?
You can book an appointment with Dr. Robert A. Gelfand by calling their office at 203-432-0335. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Robert A. Gelfand a top-rated expert for Diabetic Hyperglycemic Hyperosmolar Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert A. Gelfand is classified as an Experienced expert for Diabetic Hyperglycemic Hyperosmolar Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Robert A. Gelfand specialize in?
While Dr. Robert A. Gelfand is a Endocrinology, they have specific expertise in Diabetic Hyperglycemic Hyperosmolar Syndrome, Type 1 Diabetes (T1D), and Type 2 Diabetes (T2D). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.
Does Dr. Robert A. Gelfand participate in research or clinical trials?
Yes. Dr. Robert A. Gelfand has published 12 articles and abstracts on conditions like Diabetic Hyperglycemic Hyperosmolar Syndrome. You can view a list of Dr. Robert A. Gelfand's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Robert A. Gelfand accept my insurance?
Dr. Robert A. Gelfand accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 203-432-0335 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adrenal Insufficiency PediatricDr. Gelfand isExperienced. Learn about Adrenal Insufficiency Pediatric.
- Autosomal Dominant HypocalcemiaDr. Gelfand isExperienced. Learn about Autosomal Dominant Hypocalcemia.
- Diabetic Hyperglycemic Hyperosmolar Syndrome
- Diabetic KetoacidosisDr. Gelfand isExperienced. Learn about Diabetic Ketoacidosis.
- Familial Glucocorticoid DeficiencyDr. Gelfand isExperienced. Learn about Familial Glucocorticoid Deficiency.
- Familial Hypocalciuric Hypercalcemia Type 1
- Glucocorticoid ResistanceDr. Gelfand isExperienced. Learn about Glucocorticoid Resistance.
- HypercalcemiaDr. Gelfand isExperienced. Learn about Hypercalcemia.
- HypoaldosteronismDr. Gelfand isExperienced. Learn about Hypoaldosteronism.
- Idiopathic HypercalciuriaDr. Gelfand isExperienced. Learn about Idiopathic Hypercalciuria.
- Low Blood SugarDr. Gelfand isExperienced. Learn about Low Blood Sugar.
- Maturity Onset Diabetes of the YoungDr. Gelfand isExperienced. Learn about Maturity Onset Diabetes of the Young.
- Milk-Alkali SyndromeDr. Gelfand isExperienced. Learn about Milk-Alkali Syndrome.
- Nephrogenic Diabetes InsipidusDr. Gelfand isExperienced. Learn about Nephrogenic Diabetes Insipidus.
- ObesityDr. Gelfand isExperienced. Learn about Obesity.
- Rabson-Mendenhall SyndromeDr. Gelfand isExperienced. Learn about Rabson-Mendenhall Syndrome.
- Triple A SyndromeDr. Gelfand isExperienced. Learn about Triple A Syndrome.
- Type 1 Diabetes (T1D)Dr. Gelfand isExperienced. Learn about Type 1 Diabetes (T1D).
- Type 2 Diabetes (T2D)Dr. Gelfand isExperienced. Learn about Type 2 Diabetes (T2D).